• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Rotation Medical release initial results for ‘bioinductive’ shoulder implant

Rotation Medical release initial results for ‘bioinductive’ shoulder implant

May 18, 2017 By Sarah Faulkner

Rotation Medical's bioinductive implantRotation Medical touted initial data today from the Rebuild registry of its bioinductive implant at the annual meeting of the Arthroscopy Association of North America.

Interim results from the 1st 200 patients demonstrated significantly less post-operative pain and use of narcotics in patients who received the bioinductive implant, as well as less sling time, faster return to function and better overall shoulder rating.

Patients in the registry reported feeling better 6 months after receiving the implant than those who received traditional treatment did at 2 years. The registry is slated to follow up to 300 patients.

“Patients often opt out or delay surgery in the early stages of rotator cuff disease due to long and painful rehabilitation,” study investigator Dr. Louis McIntyre said in prepared remarks. “Initial results of the Rebuild registry demonstrate statistically significant improvements in several outcomes measures, including pain, function and overall shoulder rating.”

Data from the Rebuild registry are being compared to data in a national orthopedic database using standard rotator cuff treatment, according to the company.

“Payors and providers are increasingly looking for data that demonstrate the effectiveness of medical devices on key health economic drivers,” president & CEO Martha Shadan added. “With the results of the Rebuild registry, we believe our bioinductive implant is well-positioned to transform the treatment of rotator cuff disease, enabling patients to get back to work and other activities more quickly with less pain and use of narcotics than traditional rotator cuff repair.”

Rotation Medical’s bioinductive implant won FDA approval in March 2014. The implant was designed to induce new tissue growth after a patient suffers a rotator cuff tendon tear.

Filed Under: Clinical Trials, Implants, Orthopedics Tagged With: rotationmedical

More recent news

  • Johnson & Johnson MedTech launches new Volt plating systems for radius, humerus
  • PharmaSens, SiBionics collab on all-in-one insulin patch pump
  • Beta Bionics to pair iLet automated insulin delivery system with Abbott’s dual glucose-ketone sensor
  • Anaconda Biomed wins CE mark for funnel catheter
  • FDA approves Neuspera neuromod for urinary incontinence

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy